• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Cardiovascular screening tackles disease in NFL pros

Article

The colossal linemen of the National Football League and large folks in general may have more in common than their size. People who weigh more than 300 pounds are more than twice as likely as a lighter person to die from a heart attack or stroke, according to a study sponsored by the Living Heart Foundation.

LHF founder and former NFL quarterback Dr. Arthur "Archie" Roberts and colleagues at Mount Sinai and the Mayo Clinic sought to identify cardiovascular risk factors in retired NFL players. Researchers found that major risk factors include metabolic syndrome, sleep apnea, elevated cholesterol, cardiac enlargement, and left ventricular hypertrophy. They also found these risk factors make players, particularly linemen, twice as likely as the average person to suffer heart disease, stroke, and other cardiovascular conditions. The study will be published soon in the Journal of the American College of Cardiology.

Recent Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.